Nautilus Biotechnology Inc
(NAUT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 05-2003 | 02-2003 | 11-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,267 | -6,289 | -1,600 | 20,690 | 15,070 |
| Depreciation Amortization | 1,927 | 1,243 | 6,150 | 28,970 | 19,740 |
| Accounts payable and accrued liabilities | 57 | -107 | N/A | N/A | N/A |
| Other Working Capital | -1,048 | -912 | 10,380 | 50 | -20,850 |
| Other Operating Activity | 62 | 167 | 3,220 | 11,160 | 12,230 |
| Operating Cash Flow | $-9,269 | $-5,898 | $18,150 | $60,870 | $26,190 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -617 | -355 | -4,510 | -24,420 | -18,330 |
| Purchase Of Investment | -68,359 | -48,333 | N/A | N/A | N/A |
| Sale Of Investment | 15,001 | 11,001 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 1,300 | -50 | 0 |
| Investing Cash Flow | $-53,975 | $-37,687 | $-3,210 | $-24,470 | $-18,330 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32 | 4 | N/A | N/A | N/A |
| Other Financing Activity | 75,857 | 75,857 | -300 | 730 | 1,000 |
| Financing Cash Flow | $75,889 | $75,861 | $-300 | $730 | $1,000 |
| Beginning Cash Position | 595 | 595 | 82,950 | 45,810 | 45,810 |
| End Cash Position | 13,240 | 32,871 | 97,580 | 82,950 | 54,670 |
| Net Cash Flow | $12,645 | $32,276 | $14,630 | $37,130 | $8,850 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,269 | -5,898 | 18,150 | 60,870 | 26,190 |
| Capital Expenditure | -617 | -355 | N/A | N/A | N/A |
| Free Cash Flow | -9,886 | -6,253 | 18,150 | 60,870 | 26,190 |